Good morning, it's Paul and Jack here, with Friday's SCVR.

I'm getting my 2nd AstraZeneca jab this afternoon, so am looking forward to that. The NHS App is very good, I downloaded it onto my phone last night, it keeps a record of your jabs, which could be useful in future to prove you've been vaccinated (for travel, etc), so you might want to look at downloading it yourself, if you haven't already done so.

Timing - we're making good progress, so should all be done by 1pm official finish time, or earlier. Today's report is now finished.

Agenda -

Paul's Section:

Spaceandpeople (LON:SAL) (I hold) - too small for the SCVR, at only £3m mkt cap, but seeing as I've looked at its 2020 results out this morning anyway, might as well post my brief notes. It's a speculative punt, but has survived the lockdown, and sounds like there is some potential here, with (previously announced) new contracts. High risk warning.

Polarean Imaging (LON:POLX) (I hold) - highly speculative, but several shrewd friends tell me this MRI scanning company looks to have interesting potential. High risk warning on this one, so won't appeal to most readers.

Creo Medical (LON:CREO) - another highly speculative jam tomorrow medical devices company, issuing results for FY 12/2020. Prodigious cash burn. I've got no idea how to assess companies like this, so am neutral.

Tungsten (LON:TUNG) - some signs of life here, in today's year end update for FY 04/2021.

Jack's Section:

Chapel Down (OFEX:CDGP) - perennially loss-making, cash-burning UK wine producer. Disposal of non-core beer business and a strong performance in ecommerce and direct to consumer are positives, as is the strong market position, but there's still plenty to be done to show that this can become a sustainably profitable business for investors.


Paul’s Section

Spaceandpeople (LON:SAL)

(I hold)

* High risk, extremely small *

14.25p - mkt cap £3.0m

Only a tiny position, which got through to my Spreadex account due to a clerical error. It’s too small for the SCVR, at only £3m mkt cap, but seeing as I've looked at its announcement today anyway, might as well quickly post my notes below.

FY 12/2020 results, out this morning.

It’s still in business, and has survived the pandemic,…

Unlock this Article with a 14 day free trial

or Unlock with your email

Already have an account?
Login here